TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00110877
Recruitment Status : Completed
First Posted : May 16, 2005
Last Update Posted : July 3, 2015
Information provided by (Responsible Party):
Tibotec Pharmaceuticals, Ireland